Wall Street futures, dollar dip after U.S. government shutdown, Asia resilient
January 22, 2018Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
January 22, 2018Sanofi to buy U.S. haemophilia group Bioverativ for $11.6 billion
at
PARIS (Reuters) – French healthcare group Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion, in a deal which it said would boost earnings and strengthen its presence in treatments for rare diseases.
Powered by WPeMatico
